A pioneer in regenerative medecine

CellProthera is a medical biotech company founded in 2008 in Mulhouse (France). Its activity is currently focused on the development of a revolutionary therapeutic approach allowing the regeneration of myocardial tissue following acute myocardial infarct by injection of a cell graft containing autologous adult stem cells (ASC) sampled directly from the patient..

The need is overwhelming, solving it our goal

CellProthera is in clinical phase, currently conducting an international clinical trial phase I/IIB including 44 European patients and about to start a supplementary trial in Singapore. Next will follow a phase III in both Europe and North America.